首页/数据集/Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant

Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant

NIAID Data Ecosystem2026-05-01 收录

药物设计

蛋白质-配体复合物结构

数据链接：

https://www.rcsb.org/structure/6AU5 数据链接链接失效反馈

官方服务：

资源简介：

Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant

应用场景：

创建时间：

2023-11-15

药物设计

癌症治疗

Human Topoisomerase I (hTop1p) is a ubiquitous enzyme that relaxes supercoiled DNA through a conserved mechanism involving transient breakage, rotation, and binding. Htop1p is the molecular target of

DataCite Commons2022-11-11 更新80

Additional file 5 of QSAR-Co-X: an open source toolkit for multitarget QSAR modelling

药物设计

QSAR建模

Additional file 5. Folder (CS_4) containing the input file of SFS-LDA and GB models and the results (i.e., the output files from the current toolkit) obtained from the SFS-LDA for Case study-4.

DataCite Commons2021-04-16 更新20

Crystal Structure of CbpF in Complex with Atropine by Co- Crystallization

蛋白质-配体复合物结构

药物作用机制

Crystal Structure of CbpF in Complex with Atropine by Co- Crystallization

NIAID Data Ecosystem00

MOESM4 of Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

药物设计

分子对接

Additional file 4. CSV file of computed F1 scores of the A2AR docking model.

DataCite Commons2020-08-31 更新60

Is it feasible to use AI-based drug design methods in the process of generating effective COVID-19 inhibitors? A validation study using molecular docking, molecular simulation, and pharmacophore methods

药物设计

COVID-19抑制剂

Although the COVID-19 pandemic has been brought under control to some extent globally, there is still debate in the industry about the feasibility of using artificial intelligence (AI) to generate COV

Taylor & Francis Group2025-11-12 更新00

Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant

资源简介：

相关数据集